Yasuaki Nakagawa Selected Research

Hypokalemia

7/2019

Overexpression of the HCN2 channel increases the arrhythmogenicity induced by hypokalemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuaki Nakagawa Research Topics

Disease

25	Heart Failure 07/2022 - 05/2003
6	Cardiomegaly (Heart Hypertrophy) 12/2013 - 10/2003
5	Knee Osteoarthritis 04/2022 - 01/2008
5	Osteonecrosis (Kienbock's Disease) 12/2021 - 01/2002
5	Myocardial Infarction 01/2019 - 05/2003
5	Fibrosis (Cirrhosis) 01/2016 - 10/2003
4	Osteoarthritis 12/2021 - 01/2002
4	Sudden Death 01/2016 - 06/2009
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2014 - 06/2009
3	Febrile Neutropenia 01/2015 - 10/2006
3	Hypertrophy 12/2013 - 10/2003
2	Ischemia 07/2022 - 10/2021
2	Inflammation (Inflammations) 12/2021 - 10/2021
2	Pheochromocytoma 01/2018 - 06/2013
2	Pain (Aches) 06/2017 - 11/2014
2	Venous Thromboembolism 05/2017 - 07/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2014 - 01/2012
2	Cardiomyopathies (Cardiomyopathy) 10/2009 - 06/2009
2	Hematologic Neoplasms (Hematological Malignancy) 04/2008 - 10/2006
1	Rheumatoid Arthritis 10/2023
1	Edema (Dropsy) 01/2023
1	Stress Fractures (Stress Fracture) 01/2023
1	Necrosis 01/2023
1	Bone Resorption 07/2022
1	Osteophyte 12/2021
1	Hyperthyroidism 10/2021
1	Atrial Fibrillation 10/2021
1	Pericardial Effusion 10/2021
1	Obesity 10/2021
1	Acute Coronary Syndrome 10/2021
1	Dyspnea (Shortness of Breath) 10/2021
1	Thymoma (Thymic Carcinoma) 01/2021
1	Congenital Abnormalities (Deformity) 11/2020
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Diabetes Mellitus 01/2020
1	Hypokalemia 07/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Atherosclerosis 01/2019
1	Stroke (Strokes) 01/2019
1	Cardio-Renal Syndrome 01/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2018

Drug/Important Bio-Agent (IBA)

19	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2022 - 05/2003
7	Biomarkers (Surrogate Marker)IBA 07/2022 - 06/2013
7	Atrial Natriuretic Factor (ANF)IBA 01/2019 - 10/2003
6	pro-brain natriuretic peptide (1-76)IBA 10/2021 - 01/2012
5	Angiotensin IIIBA 12/2013 - 05/2003
4	CytokinesIBA 07/2022 - 01/2005
4	Hormones (Hormone)IBA 07/2022 - 06/2009
4	CurcuminIBA 04/2022 - 11/2014
4	RE1-silencing transcription factorIBA 05/2013 - 12/2006
3	Natriuretic PeptidesIBA 01/2019 - 08/2005
3	Peptides (Polypeptides)IBA 01/2018 - 06/2013
3	Type 1 Angiotensin ReceptorIBA 01/2016 - 08/2007
3	Messenger RNA (mRNA)IBA 09/2015 - 05/2003
3	atrial natriuretic factor receptor AIBA 06/2009 - 02/2004
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 07/2022 - 10/2011
2	SteroidsIBA 12/2021 - 08/2003
2	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2020 - 01/2020
2	empagliflozinIBA 10/2020 - 01/2020
2	SodiumIBA 01/2020 - 08/2005
2	Apolipoproteins E (ApoE)IBA 01/2019 - 11/2012
2	AdrenomedullinIBA 01/2018 - 06/2013
2	NitrendipineIBA 10/2014 - 09/2009
2	Itraconazole (Sporanox)FDA LinkGeneric 04/2008 - 10/2006
2	Guanylate Cyclase-Coupled ReceptorsIBA 08/2005 - 10/2003
1	Neprilysin (Neutral Endopeptidase)IBA 07/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 07/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	TBP1901IBA 12/2021
1	Indicators and Reagents (Reagents)IBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2021
1	Sodium-Glucose Transport ProteinsIBA 10/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	dapagliflozinIBA 01/2020
1	ElectrolytesIBA 07/2019
1	Cyclic NucleotidesIBA 07/2019
1	PotassiumIBA 07/2019
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 07/2019
1	Ion Channels (Ion Channel)IBA 07/2019
1	PCSK9 InhibitorsIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	myocardinIBA 01/2019
1	Ezetimibe (Zetia)FDA Link 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 10/2017

Therapy/Procedure

6	Osteotomy 10/2023 - 01/2002
4	Therapeutics 01/2020 - 05/2012
4	Knee Replacement Arthroplasty (Total Knee Replacement) 06/2017 - 06/2007
3	Transplantation 01/2021 - 08/2003
2	Arthroplasty 05/2017 - 07/2014
1	Injections 12/2021
1	Intra-Articular Injections 12/2021
1	Autologous Transplantation 12/2021
1	Replacement Arthroplasty 12/2021
1	Radiotherapy 01/2021
1	Heart-Assist Devices 01/2021